Skip to main content
Download PDF

M6A demethylase FTO-stabilized exosomal circBRCA1 alleviates oxidative stress-induced granulosa cell damage via the miR-642a-5p/FOXO1 axis

Journal of Nanobiotechnology volume 22, Article number: 367 (2024) Cite this article

Abstract

Background

Premature ovarian insufficiency (POI) is an important cause of female infertility and seriously impacts the physical and psychological health of patients. Human umbilical cord mesenchymal stem cell-derived exosomes (HucMSCs-Exs, H-Exs) have exhibited protective effects on ovarian function with unclear mechanisms.

Methods

A comprehensive analysis of the Gene Expression Omnibus (GEO) database were used to identify POI-associated circRNAs and miRNAs. The relationship between HucMSC-derived exosomal circBRCA1/miR-642a-5p/FOXO1 axis and POI was examined by RT-qPCR, Western blotting, reactive oxygen species (ROS) staining, senescence-associated β-gal (SA-β-gal) staining, JC-1 staining, TEM, oxygen consumption rate (OCR) measurements and ATP assay in vivo and in vitro. RT-qPCR detected the expression of circBRCA1 in GCs and serum of patients with normal ovarian reserve function (n = 50) and patients with POI (n = 50); then, the correlation of circBRCA1 with ovarian reserve function indexes was analyzed.

Results

Herein, we found that circBRCA1 was decreased in the serum and ovarian granulosa cells (GCs) of patients with POI and was associated with decreased ovarian reserve. H-Exs improved the disorder of the estrous cycles and reproductive hormone levels, reduced the number of atretic follicles, and alleviated the apoptosis and senescence of GCs in rats with POI. Moreover, H-Exs mitigated mitochondrial damage and reversed the reduced circBRCA1 expression induced by oxidative stress in GCs. Mechanistically, FTO served as an eraser to increase the stability and expression of circBRCA1 by mediating the m6A demethylation of circBRCA1, and exosomal circBRCA1 sponged miR-642a-5p to block its interaction with FOXO1. CircBRCA1 insufficiency aggravated mitochondrial dysfunction, mimicking FTO or FOXO1 depletion effects, which was counteracted by miR-642a-5p inhibition.

Conclusion

H-Exs secreted circBRCA1 regulated by m6A modification, directly sponged miR-642a-5p to upregulate FOXO1, resisted oxidative stress injuries in GCs and protected ovarian function in rats with POI. Exosomal circBRCA1 supplementation may be a general prospect for the prevention and treatment of POI.

Graphical Abstract

Background

Premature ovarian insufficiency (POI) is a disease characterized by early menopause before 40 years of age, accompanied by an elevation of follicle-stimulating hormone (FSH ≥ 25 IU/L on two occasions over 4 weeks apart), and ultimately leads to female infertility [1]. POI is one of the most common reproductive endocrine disorders and affects 1–2% of women of childbearing age [2]. Ovarian granulosa cells (GCs) dysfunction triggered by reactive oxygen species (ROS) exposure is an important causal factor for POI [3]. Mitochondria act as intracellular organelles for producing ROS, and disrupted mitochondrial function induces the senescence and even apoptosis of GCs, thereby contributing to the occurrence of POI [4, 5].

The current conventional clinical treatment methods for POI are characterized by several side effects, and most do not effectively restore the physiological functions of the ovaries [6]. Thus, novel treatment options for mitochondrial disorder-linked POI require further exploration. Transplantation of human umbilical cord mesenchymal stem cell-derived exosomes (HucMSCs-Exs, H-Exs) could prevent the formation of oxidative stress-induced ROS and DNA damage and thus comprehensively rescue GCs damage by transporting therapeutic proteins, nucleic acids and lipids. This method is considered a promising regenerative medicine approach and has received substantial attention in the management of POI with high efficacy and low immunogenicity and toxicity [7, 8]. Recently, noncoding RNAs (ncRNAs), including microRNAs, long ncRNAs and circRNAs carried by H-Exs, have begun to be explored in ovaries [9,10,11].

CircRNAs, a novel type of ncRNA characterized by a covalently closed loop without a 5′ end cap or 3′ poly(A) tail [12], are highly conserved and characterized by tissue-specific expression patterns [13] and mainly remain in the cytoplasm and function as miRNA sponges [14]. The loop structures without free ends make circRNAs more stable than other RNAs, and thus, circRNAs are ideal biomarkers and therapeutic targets for multiple diseases [15]. Recently, differentially expressed circRNAs have been discovered in human GCs during maternal aging, suggesting the involvement of circRNAs in the maintenance of ovarian function [16]. However, the role of exosomal circRNAs in the regulation of POI pathogenesis remains largely unknown.

N6-methyladenosine (m6A) modification is the most abundant internal modification of both coding and noncoding RNA polymerase II transcripts with major impacts on their dynamic regulation [17]. Reportedly, m6A controls the post-transcriptional regulation of circRNAs, including nuclear export, backsplicing, and translation, by recruiting specific m6A reader/eraser proteins [18]. Abnormally elevated levels of m6A in the ovaries have been implicated in POI [19, 20]. The “writers” of m6A are mainly composed of the METTL3/METTL14 methyltransferase complex and its cofactor WTAP [21]. The process of demethylation is primarily mediated by the methylase fat mass and obesity-associated (FTO) and ALKBH5 [22, 23]. The most recent studies found that FTO acted as an "eraser" of m6A methylation and decreased apoptosis in GCs by regulating the expression of BNIP3 [24] and retarding FOS-dependent ovarian aging [25], suggesting that FTO may play a non-negligible role in the regulation of ovarian function. Based on available published data, a clear view of m6A modification in circRNAs has been established, and m6A modification enhanced the transcriptome stability of circMDK, which partially accounts for the significant upregulation of circMDK [26]. In addition, circNSUN2 m6A modification facilitated cytoplasmic export and stabilized HMGA2 [27].

In the present study, we screened and identified the expression and functions of hsa_circ_0043949 (circBRCA1) derived from BRCA1 and examined the detailed mechanism of exosomal circBRCA1 in the regulation of POI pathology. Functional experiments revealed that FTO acted as a novel transcriptional activator of circBRCA1 via m6A demethylation, which upregulated circBRCA1 expression. Moreover, exosomal circBRCA1 led to an increase in the target gene FOXO1 through competitive binding to miR-642a-5p, thereby repairing oxidative damage in GCs. Our findings highlight that exosomal circBRCA1 secreted from HucMSCs improves ovarian function and ameliorates mitochondrial damage, leading to the development of specific therapies for POI.

Methods

Patients and samples

50 patients with POI (POI group) who were treated with in vitro fertilization or intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) at the Reproductive Center of the Fourth Affiliated Hospital of Jiangsu University (Zhenjiang Maternal and Child Health Hospital) were selected from June 2021 to July 2023; 50 patients with normal ovarian reserve function (NC group) who underwent IVF/ICSI-ET due to male and/or tubal factors were selected as controls during the same period. The age and BMI of the 2 groups were compared, and the differences were not statistically significant (P > 0.05), and were comparable.

All patients with POI in this study were clearly diagnosed by attending physicians and above. The collection of patients' GCs and serum samples (taken on an empty stomach in the early morning of the 2nd-3rd day of menstruation) was approved by the Ethics Committee of The Fourth Affiliated Hospital of Jiangsu University (Zhenjiang Maternal and Child Health Hospital), which was in accordance with the ethical requirements, and all subjects participated voluntarily and signed a written informed consent. The basic information of the patients is shown in Table S1.

Cell culture and transfection

The human granulosa cell line KGNs and the human embryonic kidney cell line 293 T were purchased from the Chinese Academy of Sciences Cell Bank (Shanghai, China), cultured in F12/DMEM medium (Gibco, USA) with 10% FBS (Gibco, USA). Human umbilical cord tissues were obtained from the Fourth Affiliated Hospital of Jiangsu University, and each parturient woman signed an informed consent form in advance. HucMSCs were isolated as previously reported [28] and cultured in α-MEM (Gibco, USA) with 10% FBS (Gibco, USA). All cells maintained in a humidified incubator at 37 °C with 5% CO2.

The si-circBRCA1, si-FOXO1, si-FTO, si-ALKBH5, miR-642a-5p inhibitor, biotin-miR-642a-5p and the corresponding controls (si-NC, miR-NC, biotin-miR-NC) were purchased from Genepharma (Suzhou, China). We performed transfection using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions.

Isolation and characterization of H-Exs

When the degree of HucMSCs at passage 3 to 5 fusion reached 80% ~ 90%, FBS were replaced with Ex-free FBS, and the HucMSCs continued to be cultured for 48 h. The cell supernatant was centrifuged at 4 °C, 2000 g for 20 min to remove cellular debris and concentrated using ultrafiltration device (UFC900396, Millipore, USA) at 4 °C, 2000 g for 30 min. H-Exs were isolated using total exosome isolation kit (ECS; Umibio, Shanghai, China). Dissolved the H-Exs in PBS (Gibco, USA) and store them at −80 ℃ for subsequent experiments. Purified H-Exs was labeled with PKH26 (Sigma-Aldrich, USA) for Exs uptake assays.

We observed the size and structure of H-Exs with a transmission electron microscope (TEM) and nanoparticle tracking analysis (NTA), and tested the protein marker CD9 and CD63 of H-Exs by Western Blot analysis.

Fish

The Cy3-labeled hsa_circ_00043949 (circBRCA1) probe was designed and synthesized by GenePharma (Suzhou, China). The sequence of the probe is 5′-CCTCTGACTTCAAAATCATG TGTGCCAAGGGTGAATGATG-3′. The RNA FISH kit was purchased by GenePharma (Suzhou, China). KGNs were grown on round coverslips and processed according to the kit's instruction. FISH probes were diluted (1:50), denatured, balanced and added to KGNs at 37 °C overnight. After hybridization, cells were stained with DAPI for 15 min at room temperature. Finally, the results were observed with fluorescence microscope (Leica Microsystems, Mannheim, Germany).

Nucleus-cytoplasm extraction

Follow the manufacturer's instructions, the Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime, Shanghai, China) was used to isolate the nucleus and cytoplasm of KGNs. RNA was extracted from the nucleus and cytoplasm respectively, and the expression level of circBRCA1 in the nucleus and cytoplasm was detected by RT-qPCR according to the above method. GAPDH was used as the cytoplasmic control and U6 was used as the nuclear control.

ActD and DAA treatment

After 0 h, 6 h, 12 h, and 24 h of KGNs with 2 mg/mL actinomycin D (Sigma, USA), total RNA is extracted for PT-qPCR to assess the stability of circBRCA1 and its linear gene BRCA1. After 48 h of KGNs with DAA treatment, total RNA was extracted for PT-qPCR to detect differential expression of circBRCA1.

Western blot

Samples of cells and ovarian tissues were lysed by using radioimmunoprecipitation assay (RIPA) lysis buffer (Solarbio, Beijin, China) containing protease inhibitor (Solarbio, Beijin, China). Determined the protein concentration of the samples, added 5 × Lodding buffer (Beyotime, Shanghai, China) and boiled in the water bath for 5 min. Electrophoresis was performed on 8% or 10% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) and then transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, USA). The membranes were blocked with 5% nonfat milk for 2 h, and then incubated with anti-FOXO1 (Abcepta, Suzhou, China, 1:500), anti-SOD2 (Abcam, USA, 1:1000), anti-P21 (CST, USA, 1:1000) or anti-GAPDH (Proteintech, Wuhan, China, 1:10000) overnight at 4 °C. After the anti-IgG (Biosharp, China, 1:10000) were incubated at room temperature for 1.5 h, the signals were detected by the enhanced chemiluminescence reagent kit (ECL; Vazyme, Nanjing, China) and alyzed by Image J software.

RNA and gDNA extraction and quantitative real‑time polymerase chain reaction (RT-qPCR)

According to the instructions, tissues and cells were lysed in TRIzol reagent (Ambion, USA) to extract total RNA. Genomic DNA (gDNA) was extracted from KGNs by the Genomic DNA kit (Tiangen, Beijing, China). Reverse transcriptased mRNA by HiScript II Q RT SuperMix (Vazyme, Nanjing, China). MiRNA Universal SYBR qPCR Master Mix (Vazyme, Nanjing, China) was used for miRNA cDNA synthesis. Quantitative reverse transcription polymerase chain reaction (PCR) was performed using ChamQ Universal SYBR qPCR Master Mix (Vazyme, Nanjing, China). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or U6 was utilized as an endogenous reference. All primers were designed and synthesized by Shanghai Sangon Biotech and listed in Table S2.

ROS assay

The Reactive Oxygen Species Assay Kit (Beyotime, Shanghai, China) is used to evaluate the level of ROS in KGNs and rat ovarian tissues. Applied DCFH-DA probes to sections of KGNs or ovarian tissues in different experimental groups, the samples were incubated at 37 °C for 30 min in a light shielded humidifying incubator and washed with PBS for 1–2 times. The nuclei were incubated with DAPI (Solarbio, Beijin, China) at room temperature in dark condition for 10 min, cleaned with PBS for 1–2 times, and the images were taken immediately under fluorescence microscope (Leica Microsystems, Mannheim, Germany). Image J software is used to analyze fluorescence intensity.

Mitochondrial membrane potential assay

The Mitochondrial membrane potential assay kit with JC-1 (Beyotime, Shanghai, China) was used to detect the mitochondrial membrane potential of KGNs. JC-1 probes (1 mg/L) were loaded at 37 °C for 20 min. After washed with PBS for 1–2 times, immediately taken pictures with fluorescence microscope (Leica Microsystems, Mannheim, Germany), Image J software is used to analyze fluorescence intensity.

Senescence-associated β-gal assay

The Senescence β-Galactosidase Staining Kit (Beyotime, Shanghai, China) reflected the aging of KGNs, and SA-β-gal staining was conducted according to the manufacturer’s instructions. The cells were cultured in six-well plates, fixed with 1 ml of fixative solution per well for 15 min at room temperature. The cells were washed twice with PBS and incubated overnight with freshly prepared SA-β-gal staining solution in the aforementioned incubator. The number of senescent cells was evaluated by counting the number of blue-stained cells under the light microscope.For rat ovarian tissue section staining, the frozen slices were fixed with fixative solution for 15 min and stained overnight with SA-β-gal staining solution in the incubator.Then, the frozen slices were restained with eoxin dye and observed under the light microscope (Leica Microsystems, Mannheim, Germany).

Oxygen consumption rate (OCR) measurements and ATP levels

OCR measurements were performed using a Seahorse Bioscience XFp Extracellular Flux Analyzer instrument (Agilent Technologies AG, Basel, Switzerland). Oxygen consumption was measured every 10 min and the following injections were performed after every three measurements: (1) 1 mM oligomycin, (2) 1 mM FCCP, and (3) 2 mM rotenone and 2 mM antimycin A. The results were normalized to cell number quantified by DNA content.

ATP levels were determined using the ATP Assay Kit (Beyotime, China) according to the manufacturer's instructions.

Methylated RNA immunoprecipitation (MeRIP) assay

The RNA Immunoprecipitation (RIP) Kit (BersinBio, Guangzhou, China) was used to validate the interaction between circBRCA1 and m6A. KGNs lysates were incubated with the prepared magnetic beads along with anti-m6A (Abcam, USA, 4 μl) or anti-IgG (BersinBio, Guangzhou, China, 4 μl) at 4 °C. Collected and washed magnetic beads. RT-qPCR was employed to test circBRCA1 expression.

Establishment of the model of POI and treatment with H-Exs

Five-week-old Sprague Dawley (SD) female rats were purchased from the Animal Experiment Center of Jiangsu University. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the Fourth Affiliated Hospital of Jiangsu University.

To establish the POI rat model, rats were injected intraperitoneally with 8 mg/kg cyclophosphamide (CTX) on the first day. Thereafter, rats were injected intraperitoneally with 2 mg/kg CTX daily for 13 days. A normal control group (NC) was injected with normal saline instead of CTX [29]. On the fifteenth day of model establishment, POI rats were randomly divided into four groups, which received PBS, Exs, H-Exs-si-circBRCA1 and H-Exs-si-FTO by tail vein injection.

Assessment of rat estrous cycles

Vaginal smears of rats were obtained at 9:00 a.m. each day to observe the estrous cycle in each group. The normal estrous cycle in rats consists of the following four consecutive phases: proestrus, estrus, metestrus, and diestruss, which were identified according to the presence or absence of cornified epithelium, nucleated epithelial cells, and leukocytes [29] Experiments included rats with at least two consecutive normal estrous cycles.

Ovarian morphology analysis and follicle counts

Six pairs of ovaries were collected after 2 weeks of H-Exs treatment, photographed and weighed to record ovarian size and ovarian index. Fresh ovarian tissues were fixed with 4% paraformaldehyde for one day, dehydrated, paraffin embedded and cut into 4 μm sections for the following experiments. Sections were stained with hematoxylin and eosin (HE). Ovarian morphology was observed using Pathology Image Scanner (Pannoramic MIDI, Hungary), and the number of follicles was counted according to the previous method [30].

Immunohistochemistry

Sections were deparaffinized and rehydrated and heated in a microwave oven to repair the antigen. Then, sections were incubated with primary antibodies, including FOXO1 (Abcepta, China, 1:50), overnight at 4 °C. Subsequently, sections were incubated with a horseradish peroxidase-conjugated secondary antibody (Biosharp, China, 1:10000) was incubated at room temperature in the dark. Counterstained the sections with hematoxylin (Biosharp, China), and imaged with the Pathology Image Scanner (Pannoramic MIDI, Hungary).

Immunofluorescence Staining

Sections were permeated by 0.3% Triton X-100, blocked with 10% FBS (Gibco, USA), and incubated in the presence of primary antibodies, including FSHR (Proteintech, China, 1:200), Ki67 (Abcam, USA, 1:3000), and FOXO1 (Abcepta, China, 1:50) at 4 °C overnight, followed by incubation with a horseradish peroxidase-conjugated secondary antibody (Biosharp, China, 1:10000) for 1 h at 37 °C in the dark. The sections were counterstained with DAPI and imaged using the Pathology Image Scanner (Pannoramic MIDI, Hungary).

Elisa

An enzyme-linked immunosorbent assay kit (ImmunoWay, USA) was used to detect AMH, FSH, LH and E2. The serum samples were collected and incubated with ninety-six-well plates with antibodies at room temperature for 2 h. The serum hormone levels were measured by the microplate reader (Bio-Rad, USA).

Statistical analysis

The experimental data were representative of three independent experiments at least, and the GraphPad Prism software (version 9.0 for Windows) was used for calculations and generated the statistical graph. The differences between two groups were analyzed using two-tailed t-tests. One-way analysis of variance (ANOVA) was used for the multiple group comparisons. When P < 0.05, it was considered statistically significant in this study. Pearson correlation and linear regression analysis were performed to evaluate the correlation between circBRCA1 and clinical ovarian reserve indicators in the POI group (n = 50) and all participants (n = 100). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Results

H-Exs alleviated oxidative damage by improving mitochondrial function in KGNs

Previously, we demonstrated that H-Exs were able to alleviate GCs senescence by reducing ROS damage [31]. Considering that mitochondria are the first sensors of senescence and target organs of ROS production [2, 5, 32], we hypothesize that Ex-mediated antisenescence effects may be associated with improvements in the mitochondrial function of GCs. To illustrate this, we isolated and characterized H-Exs and evaluated the effect of H-Exs in the repair of oxidative damage-induced mitochondrial dysfunction in KGNs (the in vitro cell line of GCs). As revealed by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and Western blot analysis, H-Exs were vesicles with a spherical shape and a bilayer membrane structure (Fig. 1A), approximately 100 nm in diameter (Fig. 1B), and highly expressed the exosome-surface marker proteins CD9 and CD63 (Fig. 1C).

Fig. 1
figure 1

CircBRCA1 is significantly upregulated in oxidatively damaged KGNs treated with H-Exs. A Scanning of H-Exs using TEM. (scale bar = 100 nm) B The size range of the H-Exs checked by NTA. C Western blot analysis of H-Ex-related markers CD9 and CD63. D Schematic diagram of HucMSCs or H-Exs co-culture with KGNs. E Internalization of PKH-26-labeled-H-Exs was analyzed in H2O2-KGNs co-cultured with H-Exs. Red: PKH26-H-Exs staining; Blue: nuclear staining. (scale bar = 50 µm) F JC-1 staining was used to detect the changes of MMP. (scale bar = 75 µm) G Scanning the mitochondria of KGNs using TEM. (scale bar = 200 nm) H Oxygen consumption rate of KGNs. I Hierarchical clustering of diferentially expressed circRNAs in samples of GCs from women with advanced age (AA, ≥ 38 years) and young age (YA, ≤ 30 years). J Relative expression levels of circBRCA1 in GCs and serum of patients with normal ovarian function (NC, n = 50) and POI patients (POI, n = 50) were determined by RT-qPCR. K Relative expression levels of circBRCA1 in KGNs and H2O2-KGNs were determined by RT-qPCR. L Relative expression levels of circBRCA1 in KGNs after HucMSCs/H-Exs transplantation were determined by RT-qPCR. M FISH assay was used to illustrate that CY3-marked-circBRCA1 in H-Exs was internalized by H2O2-KGNs

Full size image

In the coculture systems (Fig. 1D), PKH26-marked-H-Exs were absorbed by KGNs (Fig. 1E). Subsequently, we constructed in vitro models of oxidative injury using H2O2 (H2O2-KGNs), which was mainly characterized by elevated ROS, senescence marker P16, P21 and SA-β-gal activity and decreased levels of the antioxidant enzymes Gpx and SOD2 in KGNs (Supplementary Fig. 1A-G).

Notably, we found that H2O2 treatment hindered the mitochondrial activity of KGNs, as evidenced by decreased mitochondrial membrane potential (MMP), OCR and ATP levels and increased abnormal mitochondria (Fig. 1F–H and Supplementary Fig. 1H, I), indicating that H2O2 treatment had a significant inhibitory effect on the mitochondrial respiratory chain. However, HucMSCs/H-Exs transplantation not only ameliorated oxidative stress-induced cellular senescence but also repaired mitochondrial function (Fig. 1F–H and Supplementary Fig. 1A-I). Nevertheless, GW4869 addition (for inhibiting neutral sphingomyelinase and blocking H-Exs release) impaired HucMSC-mediated repair function (Fig. 1F–H and Supplementary Fig. 1A-I), suggesting that HucMSCs reduced oxidative damage in H2O2-KGNs by delivering H-Exs.

CircBRCA1 is significantly upregulated in oxidatively damaged KGNs treated with H-Exs

Recently, the H-Exs transfer of ncRNAs (noncoding RNAs) was regarded as a novel and important mechanism of genetic exchange between cells, and the role of circRNAs in POI is receiving increasing attention. To search for circRNAs that may be associated with POIs, we analyzed data from the GEO dataset (GSE97193), including RNA-seq data of circRNAs in GCs with three advanced age (AA, > 38 years) and three young (YA, < 30 years) women undergoing IVF/ICSI-ET, and found that a total of 179 circRNAs, 61 downregulated and 118 upregulated circRNAs, were differentially expressed in GCs. The heatmap was used to illustrate the differentially expressed pattern of circRNAs (Fig. 1I). Among the top 30 most significantly downregulated circRNAs, by RT-qPCR, we verified that only hsa_circ_0043949 was significantly decreased in GCs and serum of patients with POI and in H2O2-KGNs (Fig. 1J, K), while this molecule was obviously increased in H2O2-KGNs after coculture with H-Exs (Fig. 1L). Consistently, hsa_circ_0043949 was enriched in HucMSCs/H-Exs (Supplementary Fig. 1J), and its host parental gene was associated with mitochondrial function [33,34,35], which was selected for our next studies. Hsa_circ_0043949 was further referred to as circBRCA1 because it consists of exons of BRCA1. As expected, FISH analysis revealed that Cy3-marked circBRCA1 in H-Exs was internalized by H2O2-KGNs (Fig. 1M).

Characterization and identification of circBRCA1

The 213-bp-long circBRCA1 is formed by circularization of exons 19–21 of the BRCA1 gene, which is located at chromosome chr17(q21,31):41,201,137–41,209,152 (Fig. 2A). Then, we used Sanger sequencing to confirm whether exons 19–21 of the BRCA1 gene were backspliced to form a closed loop structure (Fig. 2B). Because head-to-tail splicing could be the consequence of either transsplicing or genomic rearrangements, we designed special convergent primers for circBRCA1 and divergent primers to amplify circBRCA1 by using cDNA and gDNA, respectively. CircBRCA1 was readily amplified by the divergent primers in cDNA but not in gDNA (Fig. 2C). CircBRCA1 was markedly more stable than BRCA1 mRNA following transcriptional inhibition with actinomycin D (ActD) (Fig. 2D). Although linear BRCA1 mRNA was readily degraded by RNase R, circBRCA1 was resistant to this digestion (Fig. 2E). The above results confirmed that circBRCA1 was an abundant, circular and stable transcript and can be an ideal candidate molecule for diagnosis. Furthermore, a nuclear mass separation assay (Fig. 2F) and RNA-FISH analysis (Fig. 2G) for the subcellular distribution of circBRCA1 in KGNs revealed that circBRCA1 was predominantly localized in the cytoplasm.

Fig. 2
figure 2

H-Ex-released circBRCA1 attenuates mitochondrial damage of KGNs. A CircBRCA1 is cyclized from exons 19–21 of the BRCA1 gene. B The back-splicing junction site of circBRCA1 was verified by Sanger sequencing. C Existence of circBRCA1 in KGNs was verified by agarose gel electrophoresis. D After actD treatment, the relative expression levels of circBRCA1 and linear BRCA1 mRNA were determined by RT-qPCR. E After RNase R treatment, the relative expression levels of circBRCA1 and linear BRCA1 mRNA were determined by RT-qPCR. F Cytoplasmic and nuclear separation assay was used to detect the subcellular localization of circBRCA1 in KGNs. G FISH assay was used to illustrate the subcellular localization of circBRCA1 in KGNs. H The ROS levels were detected by DCFH-DA staining. (scale bar = 50 µm) I-J Relative expression levels of SOD2 and Gpx were determined by RT-qPCR. K Western blot analysis revealed the expression levels of SOD2 and P21 in KGNs. L Relative expression levels of P16 were determined by RT-qPCR. M SA-β-gal staining. (scale bar = 100 µm) N JC-1 staining was used to detect the changes of MMP. (scale bar = 15 µm) O Scanning the mitochondria of KGNs using TEM. (scale bar = 200 nm) P Oxygen consumption rate of KGNs. Q Statistical analysis of ATP level.

Full size image

H-Ex-released circBRCA1 attenuates mitochondrial damage in KGNs

Given the biofunction of the host gene BRCA1, circBRCA1 may be involved in the repair of mitochondrial damage [33,34,35]. To clarify this, we transfected small interfering RNAs (siRNAs) into HucMSCs to silence circBRCA1 and collected H-Exs (H-Exs-si-circBRCA1). H-Exs-si-circBRCA1 transplantation significantly reduced the uptake of circBRCA1 but not BRCA1 mRNA by H2O2-KGNs (Supplementary Fig. 2A). Subsequently, we observed that circBRCA1 KD dramatically reduced the protective effect of H-Exs against oxidative damage. As shown, the H-Exs-si-circBRCA1 group had elevated ROS accumulation (Fig. 2H and Supplementary Fig. 2B) and reduced Gpx and SOD2 levels (Fig. 2I–K and Supplementary Fig. 2C), suggesting that circBRCA1 KD attenuated the repair of oxidative damage in H-Exs. Moreover, P16 and P21 levels (Fig. 2K, L) and SA-β-gal activity (Fig. 2M and Supplementary Fig. 2D) were higher in the H-Exs-si-circBRCA1 group than in the H-Exs group, demonstrating that circBRCA1 KD reduced the antisenescent effect of H-Exs.

Next, we further confirmed the effect of exosomal circBRCA1 on mitochondrial activity. CircBRCA1 KD significantly decreased MMP, OCR and ATP levels and increased the number of aberrant mitochondria (Fig. 2N–Q and Supplementary Fig. 2E). These data illustrated that circBRCA1 deficiency leads to mitochondrial dysfunction. To verify that linear BRCA1 mRNA plays a role in H-Exs treatment of POI, we examined the expression of linear BRCA1 mRNA and found that it was barely expressed in H-Exs (Supplementary Fig. 2F). Overall, these results suggest that exosomal circBRCA1 is the key factor by which H-Exs improve mitochondrial function and repair oxidative damage in KGNs.

CircBRCA1 improves the mitochondrial function of KGNs through the miR-642a-5p/FOXO1 axis

Given that circBRCA1 is mainly localized in the cytoplasm and is highly stable, we further investigated whether circBRCA1 exerts its biological functions by sponging miRNAs. To identify abnormally expressed miRNAs in patients with POI, we analyzed the data of the GEO dataset (GSE63737), including miRNA RNA-seq data of follicular fluid from 4 advanced-age (> 36 years old) women and 5 young (< 36 years old) women. The results showed that a total of 174 miRNAs, 11 downregulated and 163 upregulated miRNAs, were differentially expressed in follicular fluid. In parallel, we predicted 9 candidate miRNAs with binding sites for circBRCA1 sequences using the miRanda database (http://www.microrna.org/microrna/home.do) (Supplementary Fig. 3A). Of these, only miR-642a-5p was present in the 163 upregulated miRNAs (Fig. 3A). To confirm the binding between circBRCA1 and miR-642a-5p, we used vectors overexpressing circBRCA1 in 293 T cells transfected with negative control (miR-NC) or miR-642a-5p mimics. The dual-luciferase reporter assay showed that miR-642a-5p mimics significantly decreased circBRCA1 luciferase activity (Fig. 3B, C). Then, we designed a 3′ terminal-biotinylated-miR-642-5p probe. As shown in Fig. 3D, circBRCA1 was significantly enriched in the pulled down material compared to the control group (Fig. 3E). Collectively, these results reveal that miR-642a-5p could directly bind to circBRCA1. Not surprisingly, miR-642a-5p was abundant in the serum and GCs of patients with POI (Fig. 3F), as well as in H2O2-KGNs (Fig. 3G). These data indicate that circBRCA1 acts as a sponge for miR-642a-5p.

Fig. 3
figure 3

CircBRCA1 acts as a sponge for miR-642a-5p. A Hierarchical clustering of diferentially expressed miRNAs in samples of follicular fluid from women with advanced age (AA, ≥ 36 years) and young age (YA, ≤ 36 years). B Schematic representation of circBRCA1 binding to miR-642a-5p. C Dualluciferase reporter assay using vectors containing overexpression of circBRCA1 in 293 T cells transfected with negative control (miR-NC) or miR-642a-5p miRNA mimics. D Schematic representation of pull-down assay with biotinylated miR-642a-5p. E Enrichment of circBRCA1 in 293 T cells after pull-down assay with biotinylated miR-642a-5p. F Relative expression levels of miR-642a-5p in GCs and serum of patients with normal ovarian function (NC, n = 50) and POI patients (POI, n = 50) were determined by RT-qPCR. G Relative expression levels of miR-642a-5p in KGNs and H2O2-KGNs. H The ROS levels were detected by DCFH-DA staining. (scale bar = 50 µm) I SA-β-gal staining. (scale bar = 100 µm) J JC-1 staining was used to detect the changes of MMP. (scale bar = 75 µm) K Scanning the mitochondria of KGNs using TEM. (scale bar = 200 nm)

Full size image

To illustrate whether miR-642a-5p is involved in circBRCA1-mediated regulation of mitochondrial function, we transfected miR-642a-5p inhibitor into H2O2-KGNs. As shown, the miR-642a-5p inhibitor reduced ROS accumulation, P16 and P21 levels and SA-β-gal activity but elevated Gpx and SOD2 levels (Fig. 3H, I and Supplementary Fig. 3B-G), supporting that the miR-642a-5p inhibitor repaired ROS-induced cellular senescence. In addition, the miR-642a-5p inhibitor elevated MMP (Fig. 3J and Supplementary Fig. 3H), OCR and ATP levels (Supplementary Fig. 3I, J) and reduced the number of aberrant mitochondria (Fig. 3K), which indicated that the miR-642a-5p inhibitor attenuated mitochondrial dysfunction. As expected, the miR-642a-5p inhibitor rescued the biological effects caused by si-circBRCA1 (Fig. 3H–K and Supplementary Fig. 3B-J). These functional experiments confirmed that circBRCA1 improved mitochondrial function by targeting miR-642a-5p to prevent oxidative damage-induced cellular senescence.

To further explore the downstream target genes of circBRCA1/miR-642a-5p in POI, we predicted the potential targets of miR-642a-5p by TargetScan (http://www.targetscan.org) and miRWalk (http://mirwalk.umm.uni-heidelberg.de/). Given the role of FOXO1 in oxidative stress regulation and cellular senescence, we finally selected FOXO1 as a potential signaling pathway downstream of circBRCA1/miR-642a-5p (Fig. 4A). To confirm the molecular binding of miR-642a-5p to FOXO1, we constructed wild-type and mutant sequences of FOXO1 and performed dual-luciferase reporter assays in 293 T cells (Fig. 4B). The results showed that miR-642a-5p reduced the luciferase activity of the wild-type reporter gene, while no significant change was found using the mutant reporter gene (Fig. 4C). The RNA pulldown assay demonstrated that FOXO1 was significantly enriched in the fraction captured by miR-642a-5p compared to that of the mimic-NC group (Fig. 4D). In addition, transfection of H2O2-KGNs with the miR-642a-5p inhibitor significantly increased FOXO1 levels, and this effect was reversed by circBRCA1 silencing (Fig. 4E). Furthermore, FOXO1 was found to be decreased in GCs and serum of patients with POI, as well as in H2O2-KGNs (Supplementary Fig. 4A, B). In summary, FOXO1 is a functional downstream target of the circBRCA1/miR-642a-5p axis.

Fig. 4
figure 4

CircBRCA1 upregulates FOXO1 expression by sponging miR-642a-5p. A The schematic drawing of the screening procedure for miR-642a-5p candidate targets. B Schematic representation of FOXO1 binding to miR-642a-5p. C Dualluciferase reporter assay using FOXO1 3′-UTR constructs containing wild-type or mutant seed sequences in 293 T cells transfected with negative control (NC) or miR-642a-5p miRNA mimics. D Enrichment of FOXO1 in 293 T cells after pull-down assay with biotinylated miR-642a-5p. E–F Relative expression levels of FOXO1 were determined by RT-qPCR and western blot analysis. G The ROS levels were detected by DCFH-DA staining. (scale bar = 50 µm) H–I Relative expression levels of SOD2 and Gpx were determined by RT-qPCR. J Western blot analysis revealed the expression levels of SOD2 and P21 in KGNs. K Relative expression levels of P16 were determined by RT-qPCR. L SA-β-gal staining. (scale bar = 100 µm) M JC-1 staining was used to detect the changes of MMP. (scale bar = 15 µm) N Scanning the mitochondria of KGNs using TEM. (scale bar = 200 nm) O Oxygen consumption rate of KGNs. P Statistical analysis of ATP level

Full size image

To verify the function of FOXO1, we transfected si-FOXO1 into H2O2-KGNs cells and found that FOXO1 levels were significantly decreased (Fig. 4F). As before, FOXO1 KD elevated ROS accumulation and P16 and P21 levels and SA-β-gal activity but reduced Gpx and SOD2 levels (Fig. 4G–L and Supplementary Fig. 4E-G), confirming that FOXO1 KD exacerbated ROS-induced cellular senescence. Furthermore, FOXO1 KD decreased MMP (Fig. 4M and Supplementary Fig. 4H), OCR and ATP levels (Fig. 4O, P) and increased the number of aberrant mitochondria (Fig. 4N), indicating aggravation of mitochondrial dysfunction. As expected, the miR-642a-5p inhibitor reversed these biological effects induced by si-FOXO1 (Fig. 4G–P and Supplementary Fig. 4E-H). In summary, we revealed a novel role for H-Exs-circBRCA1 in preventing oxidative damage-induced mitochondrial dysfunction and cellular senescence by acting as a ceRNA of miR-642a-5p, resulting in the upregulation of FOXO1.

FTO-mediated M6A demethylation facilitates circBRCA1 stability and expression

M6A modification plays a pivotal role in post-transcriptional regulation and the biogenesis of circRNAs. To verify whether the enrichment of circBRCA1 in H-Exs is related to m6A methylation, we used SRAMP (http://www.cuilab.cn/sramp) to predict potential m6A sites in circBRCA1 and found an m6A site in exon 19 (Fig. 5A and Supplementary Fig. 5A). To explore the effects of methylation on the expression of circBRCA1, we treated H2O2-KGNs with the methylation inhibitor 3-deazaadenosine and detected an increase in circBRCA1 but not BRCA1 mRNA (Fig. 5B).

Fig. 5
figure 5

FTO-mediated m6A demethylation regulates circBRCA1 stability and expression. A Prediction of m6a methylation sites on circBRCA1. B After treatment with the methylation inhibitor DAA, relative expression levels of circBRCA1and BRCA1 were detected by RT-qPCR. C Schematic diagram of Methylated RIP assay. D–E M6A RIP assay was performed to detect the enrichment rate of circBRCA1 in HucMSCs after si-ALKBH5 and si-FTO. F Relative expression levels of circBRCA1 and BRCA1 were determined by RT-qPCR. G After actinomycin D treatment, the relative expression levels of circBRCA1 were determined by RT-qPCR. H Relative expression levels of FTO in KGNs and H2O2-KGNs were determined by RT-qPCR. I The ROS levels were detected by DCFH-DA staining. (scale bar = 50 µm) J–K Relative expression levels of SOD2 and Gpx were determined by RT-qPCR. L Western blot analysis revealed the expression levels of SOD2 and P21 in KGNs. M Relative expression levels of P16 were determined by RT-qPCR. N SA-β-gal staining. (scale bar = 100 µm) O JC-1 staining was used to detect the changes of MMP. (scale bar = 15 µm) P Scanning the mitochondria of KGNs using TEM. (scale bar = 200 nm) Q Oxygen consumption rate of KGNs. R Statistical analysis of ATP level

Full size image

Knocking down the common m6A demethylase FTO but not ALKBH5 decreased the m6A methylation level of circBRCA1 (Fig. 5C–E). As expected, FTO KD reduced circBRCA1 levels (but not BRCA1 levels) and stability in HucMSCs (Fig. 5F, G). Consistently, FTO was significantly downregulated in GCs and serum of patients with POI (Supplementary Fig. 5D) and in H2O2-KGNs (Fig. 5H), indicating that the demethylation-regulating effects of FTO on circBRCA1 may be equally present in other cells, such as KGNs.

Furthermore, the effects of FTO on circBRCA1 were evaluated. We silenced FTO in HucMSCs and collected H-Exs (H-Exs-si-FTO) and found that FTO was significantly decreased (Supplementary Fig. 5D). Similar to H-Exs-si-circBRCA1, H-Exs-si-FTO reduced H-Exs-circBRCA1 levels (Supplementary Fig. 5E), which indicated that FTO KD inhibits the secretion of H-Exs-circBRCA1. Moreover, H-Exs-si-FTO increased ROS accumulation and P16 and P21 levels and SA-β-gal activity but reduced Gpx, SOD2, and FOXO1 levels (Fig. 5I–N and Supplementary Fig. 5F-I). In addition, H-Exs-si-FTO decreased MMP (Fig. 5O and Supplementary Fig. 5 J), OCR and ATP levels (Fig. 4Q, R) and increased the number of aberrant mitochondria (Fig. 5P), demonstrating that FTO KD, similar to circBRCA1 KD, reduced the repair of mitochondrial damage by H-Exs. However, simultaneous transfection of si-FTO and si-circBRCA did not further exacerbate ROS-induced cellular senescence and mitochondrial damage (Supplementary Fig. 6A-C). In summary, the above results show that FTO-mediated m6A demethylation regulates circBRCA1 stability and expression, which in turn improves mitochondrial function in KGNs.

The therapeutic efficacy of exosomal circBRCA1 in treating POI in vivo

Next, we established POI rat models and tracked the distribution of H-Exs in vivo. DIR-labeled H-Exs were injected into rats with POI via the tail vein. The strongest fluorescent signals of DIR-labeled H-Exs were detected at the site of ovarian damage in rats with POI compared to other organs, and the accumulation of the in vivo optical imaging system was time dependent, with the strongest fluorescent signals being detected at 24 h post-injection (Fig. 6A, B). The colocalization of FSHR-labeled GCs and DIR-labeled H-Exs in the rat ovaries demonstrated the targeting of H-Exs to GCs (Fig. 6C).

Fig. 6
figure 6

The therapeutic efficacy of exosomal circBRCA1 in treating POI in vivo. A Representative images of in vivo fluorescence signals of DiR-labeled H-Exs in major organs (heart, liver, spleen, lungs, and kidney) and ovaries at 0, 6, 12, 24, 48, and 72 h after tail vein injection. B Quantitative statistics of fluorescence signal intensity in different organs. C Transplanted H-Exs were tracked in rat ovaries. Red: H-Exs labeled with DIR; Blue: nuclear staining. (scale bar = 50 µm). D Schematic design for establishment of POI rat models and H-Exs treatment. E Ovaries and uterus of rats in each experimental group at the end of study. F H&E staining of ovarian sections. (scale bar = 200 µm) G Live births photos of each groups. H Pregnancy rate at 4 weeks and 8 weeks after treatment. I The number of offspring in the five groups at 4 weeks and 8 weeks after treatment

Full size image

Then, the therapeutic potential of exosomal circBRCA1 was evaluated (Fig. 6D). As shown, H-Exs injection for 2 weeks positively affected body weight (Supplementary Fig. 7A), serum hormones (Supplementary Fig. 7B) and the estrous cycle (Supplementary Fig. 7C, D), as well as ovarian size (Supplementary Fig. 7E), ovarian index (Supplementary Fig. 8A) and follicle count in rats with POI (Fig. 6F and Supplementary Fig. 8B), whereas there was almost no significant improvement in the H-Exs-si-circBRCA1 and H-Exs-si-FTO groups, suggesting that circBRCA1 KD and FTO KD impeded the effect of H-Exs in promoting the recovery of ovarian function in rats with POI. In addition, pathological sections showed that H-Exs treatment did not exhibit a negative effect on other organs (Supplementary Fig. 8C), indicating the safety and feasibility of H-Exs therapy. Four and 8 weeks after H-Exs treatment, we assessed the fertility outcomes and found that the pregnancy rate and the number of offspring in two consecutive births were lower in the H-Exs-si-circBRCA1 and H-Exs-si-FTO groups than in the H-Exs group, indicating that circBRCA1 or FTO KD inhibits the potential therapeutic effect of H-Exs in ameliorating CTX-induced fertility loss. Thus, exosomal circBRCA1 promotes the recovery of ovarian function and reproductive ability in rats with POI.

Exosomal circBRCA1 regulates GCs mitochondrial dysfunction and senescence through the miR-642a-5p/FOXO1 axis in vivo

Subsequently, we assessed the role of H-Exs in the repair of GCS mitochondrial dysfunction and senescence. Compared to PBS, H-Exs reduced ROS accumulation, P21 levels and SA-β-gal activity but elevated SOD2 levels (Fig. 7A, B and Supplementary Fig. 8D). In addition, H-Exs improved the mitochondrial morphology of GCs, as evidenced by TEM (Fig. 7C). Moreover, typical multiple fluorescence images showed the colocalization of TUNEL, Ki67 and FSHR positive cells in rat ovaries, indicating enhanced proliferation and attenuated apoptosis of GCs (Fig. 7D). However, these effects were significantly neutralized by circBRCA1/FTO KD (Fig. 7A–D and Supplementary Fig. 8D). In conclusion, circBRCA1 or FTO KD attenuated the therapeutic effect of H-Exs on rats with POI.

Fig. 7
figure 7

Exosomal circBRCA1 regulates GCs mitochondrial dysfunction and senescence through miR-642a-5p/FOXO1 axis in vivo. A The ROS levels were detected by DCFH-DA staining. (scale bar = 50 µm) B SA-β-gal staining. (scale bar = 100 µm) C Scanning the mitochondria of GCs using TEM. D Typical images of multiple fluorescence of rat ovaries. (scale bar = 1 mm)

Full size image

Compared with those of the NC group, circBRCA1 and FOXO1 levels were significantly reduced in the ovaries of rats with POI and were restored by H-Exs but not H-Exs-si-circBRCA1 or H-Exs-si-FTO treatment. Moreover, circBRCA1 and FOXO1 levels were consistently negatively correlated with miR-642a-5p levels (Fig. 8A, B). The results of IF and IHC showed the same trend consistent with the results of the in vitro study (Fig. 8C–E). Together, these data support the notion that the function of exosomal circBRCA1 in GCs mitochondrial dysfunction and senescence in vivo is likely mediated through the regulation of the miR-642a-5p/FOXO1 axis.

Fig. 8
figure 8

Exosomal circBRCA1 regulates GCs mitochondrial dysfunction and senescence through miR-642a-5p/FOXO1 axis in vivo. A Relative expression levels of circBRCA1 and miR-642a-5p in ovaries were determined by RT-qPCR. B Western blot analysis revealed the expression levels of FOXO1 in ovaries. C Relative expression levels of of circBRCA1 in ovaries were detected by FISH. D Immunohistochemistry (IHC) was used to measure the expression of FOXO1 in ovaries. Brown: positive expression of the aimed protein; Blue: nuclear staining. (scale bar = 50 µm) E Typical images of multiple fluorescence of rat ovaries. (scale bar = 1 mm)

Full size image

CircBRCA1 correlates with ovarian reserve function

To pursue this putative link between circBRCA1 and ovarian reserve function, we examined the expression level of circBRCA1 in serum and clinical ovarian reserve function indices in 50 patients with POI, and the results showed that circBRCA1 was positively correlated with serum levels of basal E2 and AMH (Fig. 9A, B) and antral follicle count (AFC) (Fig. 9I) but negatively correlated with basal FSH and LH in serum (Fig. 9C, D). Similarly, the same trend was obtained by the correlation analysis of all samples (POI and NC groups, n = 100) (Fig. 9E–I). These observations further confirm that circBRCA1 is clinically associated with ovarian reserve function and is expected to be a novel biological marker for POI (Fig. 10)

Fig. 9
figure 9

CircBRCA1 is associated with ovarian reserve function. A–D Correlation of circBRCA1 expression levels in serum with serum estradiol, AMH, FSH, and LH concentrations in POI patients (n = 50) using Pearson correlation analysis. E–H Correlation of circBRCA1 expression levels in serum with serum E2, AMH, FSH, and LH concentrations in all subjects (n = 100) using Pearson correlation analysis. I Correlation of circBRCA1 expression levels in serum with AFC in all subjects (n = 100) using Pearson correlation analysis

Full size image
Fig. 10
figure 10

Schematic of the mechanisms involving exosomal circBRCA1 in the regulation of POI

Full size image

Discussion

Excessive oxidative stress in GCs leads to impaired cumulus-oocyte complex maturation, follicle apoptosis, follicle metabolic disturbance or ovarian fibrosis, thereby leading to POI [3, 36]. This study aimed to investigate the therapeutic effects and mechanism of H-Exs on oxidative stress-induced GCs dysfunction. In this molecular event, the demethylase FTO promoted the biological stability of circBRCA1 in HucMSCs. Then, ROS-damaged GCs internalized HucMSC-secreted exosomal circBRCA1, which sponged miR-642a-5p to induce the expression of FOXO1, resulting in improved mitochondrial function and inhibition of cell senescence in GCs. Furthermore, our data indicated that H-Exs could protect against ovarian function decline and fertility in CTX-induced POI rat models, suggesting that H-Exs may be a potential nanotherapeutic agent for the treatment of POI, the pathological basis of which involves GCs dysfunction.

The high-speed development of next-generation sequencing and bioinformatics technology has allowed us to identify the vital roles of circRNAs in different biological processes, especially in carcinogenesis [37]; however, little is known about the functions of circRNAs in the pathology of POI. This study provides the first evidence that circBRCA1 derived from exons 19–21 of the BRCA1 gene contributes to oxidative damage repair in GCs. Analysis of the clinicopathological characteristics of 50 patients with POI revealed that circBRCA1 expression positively correlated with decreased ovarian reserve. Functional analyses further validated the role of circBRCA1 in improving ROS-induced GCs mitochondrial dysfunction and cellular senescence in vivo and in vitro, highlighting the important relationship between circBRCA1 and POI pathogenesis. The functions of circRNAs depend on their intracellular localization, and most cytoplasmic circRNAs act as miRNA sponges, which bind to miRNAs to release their suppression of miRNA-targeted mRNAs. Herein, we identified 9 likely miRNAs with multiple binding sites for the cytoplasmic RNA circBRCA1 by using a computational algorithm. The accurate and authentic interplay between circBRCA1 and miR-642a-5p was corroborated by pulldown and luciferase reporter assays. Further experiments revealed that miR-642a-5p exhibited vital functions in ROS damage repair in GCs. Despite this new finding, the involvement of miR-642a-5p in cell cycle arrest is not a new phenomenon [38, 39].

Subsequently, we found that FOXO1 was a downstream target of miR-642a-5p in GCs. Consistent with the competing endogenous RNA theory, a positive correlation of FOXO1 expression with circBRCA1 expression and a negative correlation of FOXO1 expression with miR-642a-5p expression were detected in GCs of patients with POI. In addition, bioinformatic analysis and functional experiments revealed that circBRCA1 released the suppressive effect of miR-452-5p on FOXO1 expression. Although the role of FOXO1 in POI remains unclear, FOXO1 has been shown to reduce GCs apoptosis during severe hypoxia [40].

M6A modification in mRNAs and circRNAs is highly prevalent and can functionally regulate the eukaryotic transcriptome, thereby affecting RNA splicing, export, localization, translation and stability [41]. The present study indicated that FTO was involved in the stability and expression of circRNAs by acting as a demethylase. Consistent with this finding, previous studies illustrated that m6A levels were significantly higher in patients with POI than in control subjects and that the decreased mRNA and protein expression levels of FTO may be responsible for the increase in m6A in POI [19, 20, 25]. Moreover, FTO has been reported to regulate APOE mRNA stability by reducing m6A levels [42]. Herein, FTO decreased the m6A level of circBRCA1 but increased circBRCA1 expression. FTO KD in H-Exs, mimicking circBRCA1 silencing effects, attenuated H-Ex-mediated oxidative damage repair and promoted mitochondrial dysfunction and cellular senescence in GCs but limited the specific mechanism by which FTO regulates circBRCA1 stability through m6A.

Conclusion

We identified the protective role of exosomal circBRCA1 in ROS damage and CTX-induced rats with POI by improving mitochondrial function and cell senescence in GCs. Mechanistically, reduced m6A levels in the circBRCA1 transcript enhanced its stability and expression, with FTO as a potential eraser in HucMSCs. Exosomal circBRCA1 reduced ROS damage by directly sponging miR-642a-5p to upregulate FOXO1 expression in GCs. In addition, circBRCA1 was downregulated in GCs and serum of patients with POI and was related to reduced ovarian reserve function. Thus, the present study proposes an H-Ex-based and ncRNA-involved approach for the therapeutic intervention of POI and highlights the potential use of circBRCA1 as a biomarker.

Availability of data and materials

Circular RNA expression profiling of human granulosa cells and miRNA profile of the human follicular fluids in young and advanced-aged women were obtained from the GEO database. The GEO accession numbers are GSE97193 and GSE63737.

Abbreviations

POI:

Premature ovarian insufficiency

HucMSCs:

Human umbilical cord mesenchymal stem cells

H-Exs:

Human umbilical cord mesenchymal stem cell-derived exosomes

GCs:

Granulosa cells

circRNAs:

Circular RNAs

miRNAs:

MicroRNAs

TEM:

Transmission electron microscopy

NTA:

Nanoparticle tracking analysis

ceRNA:

Competitive endogenous RNA

ROS:

Reactive oxygen species

SA-β-gal:

Senescence-associated β-gal

MMP:

Mitochondrial membrane potential

OCR:

Oxygen consumption rate

References

  1. Wang F, Liu Y, Ni F, Jin J, Wu Y, Huang Y, Ye X, Shen X, Ying Y, Chen J, Chen R, Zhang Y, Sun X, Wang S, Xu X, Chen C, Guo J, Zhang D. BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency. Nat Commun. 2022;13:5871.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tiosano D, Mears JA, Buchner DA. Mitochondrial dysfunction in primary ovarian insufficiency. Endocrinology. 2019;160:2353–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lin L, Gao W, Chen Y, Li T, Sha C, Chen L, Yang M, Wei H, Chen Y, Zhu X. Reactive oxygen species-induced SIAH1 promotes granulosa cells’ senescence in premature ovarian failure. J Cell Mol Med. 2022;26:2417–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dan Dunn J, Alvarez LA, Zhang X, Soldati T. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol. 2015;6:472–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang X, Yang J, Li H, Mu H, Zeng L, Cai S, Su P, Li H, Zhang L, Xiang W. miR-484 mediates oxidative stress-induced ovarian dysfunction and promotes granulosa cell apoptosis via SESN2 downregulation. Redox Biol. 2023;62: 102684.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ghahremani-Nasab M, Ghanbari E, Jahanbani Y, Mehdizadeh A, Yousefi M. Premature ovarian failure and tissue engineering. J Cell Physiol. 2020;235:4217–26.

    Article  CAS  PubMed  Google Scholar 

  7. Hu X, He C, Zhang L, Zhang Y, Chen L, Sun C, Wei J, Yang L, Tan X, Yang J, Zhang Y. Mesenchymal stem cell-derived exosomes attenuate DNA damage response induced by cisplatin and bleomycin. Mutat Res Genet Toxicol Environ Mutagen. 2023;889: 503651.

    Article  CAS  PubMed  Google Scholar 

  8. Zhang S, Huang B, Su P, Chang Q, Li P, Song A, Zhao X, Yuan Z, Tan J. Concentrated exosomes from menstrual blood-derived stromal cells improves ovarian activity in a rat model of premature ovarian insufficiency. Stem Cell Res Ther. 2021;12:178.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ding C, Qian C, Hou S, Lu J, Zou Q, Li H, Huang B. Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI. Mol Ther Nucleic Acids. 2020;21:37–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Qu Q, Liu L, Cui Y, Liu H, Yi J, Bing W, Liu C, Jiang D, Bi Y. miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Res Ther. 2022;13:352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gao W, Zhang Y, Yuan L, Huang F, Wang Y-S. Long non-coding RNA H19-overexpressing exosomes ameliorate UVB-induced photoaging by upregulating SIRT1 Via sponging miR-138. Photochem Photobiol. 2023. https://doi.org/10.1111/php.13801.

    Article  PubMed  Google Scholar 

  12. Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–91.

    Article  CAS  PubMed  Google Scholar 

  13. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–8.

    Article  CAS  PubMed  Google Scholar 

  14. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–8.

    Article  CAS  PubMed  Google Scholar 

  15. Tran AM, Chalbatani GM, Berland L, Cruz De los Santos M, Raj P, Jalali SA, Gharagouzloo E, Ivan C, Dragomir MP, Calin GA. A new world of biomarkers and therapeutics for female reproductive system and breast cancers: circular RNAs. Front Cell Dev Biol. 2020;8:50.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cheng J, Huang J, Yuan S, Zhou S, Yan W, Shen W, Chen Y, Xia X, Luo A, Zhu D, Wang S. Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes. PLoS ONE. 2017;12: e0177888.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T, He C. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117–20.

    Article  PubMed  Google Scholar 

  18. Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, Liu J, Sun Z. The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs. Mol Cancer. 2020;19:105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ding C, Zou Q, Ding J, Ling M, Wang W, Li H, Huang B. Increased N6-methyladenosine causes infertility is associated with FTO expression. J Cell Physiol. 2018;233:7055–66.

    Article  CAS  PubMed  Google Scholar 

  20. Sun X, Lu J, Li H, Huang B. The role of m6A on female reproduction and fertility: from gonad development to ovarian aging. Front Cell Dev Biol. 2022;10: 884295.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, Dai Q, Chen W, He C. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–5.

    Article  CAS  PubMed  Google Scholar 

  22. Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang Y-G, He C. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang C-M, Li CJ, Vågbø CB, Shi Y, Wang W-L, Song S-H, Lu Z, Bosmans RPG, Dai Q, Hao Y-J, Yang X, Zhao W-M, Tong W-M, Wang X-J, Bogdan F, Furu K, Fu Y, Jia G, Zhao X, Liu J, Krokan HE, Klungland A, Yang Y-G, He C. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18–29.

    Article  CAS  PubMed  Google Scholar 

  24. Wang R, Wang W, Wang L, Yuan L, Cheng F, Guan X, Zheng N, Yang X. FTO protects human granulosa cells from chemotherapy-induced cytotoxicity. Reprod Biol Endocrinol RBE. 2022;20:39.

    Article  CAS  Google Scholar 

  25. Jiang Z-X, Wang Y-N, Li Z-Y, Dai Z-H, He Y, Chu K, Gu J-Y, Ji Y-X, Sun N-X, Yang F, Li W. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging. Cell Death Dis. 2021;12:744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, Chen Z, Yang Q, Liu P, Liu S, Dong Z, Razzaq A, Tao S, Chen X, Liu Y, Xu L, Zhang Q, Li S, Peng J, Xia Z. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen R-X, Chen X, Xia L-P, Zhang J-X, Pan Z-Z, Ma X-D, Han K, Chen J-W, Judde J-G, Deas O, Wang F, Ma N-F, Guan X, Yun J-P, Wang F-W, Xu R-H, Xie D. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019;10:4695.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yan Y, Xu W, Qian H, Si Y, Zhu W, Cao H, Zhou H, Mao F. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int Off J Int Assoc Study Liver. 2009;29:356–65.

    CAS  Google Scholar 

  29. Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, Tang D, Luo Y, Xiong Z. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10:46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Wang Z, Wang Y, Yang T, Li J, Yang X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017;8:11.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yang M, Lin L, Sha C, Li T, Zhao D, Wei H, Chen Q, Liu Y, Chen X, Xu W, Li Y, Zhu X. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Investig J Tech Methods Pathol. 2020;100:342–52.

    Article  CAS  Google Scholar 

  32. Miwa S, Kashyap S, Chini E, von Zglinicki T. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest. 2022;132: e158447.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Chen Q, Lei JH, Bao J, Wang H, Hao W, Li L, Peng C, Masuda T, Miao K, Xu J, Xu X, Deng C-X. BRCA1 Deficiency impairs mitophagy and promotes inflammasome activation and mammary tumor metastasis. Adv Sci Weinh Baden-Wurtt Ger. 2020;7:1903616.

    CAS  Google Scholar 

  34. Kanakkanthara A, Kurmi K, Ekstrom TL, Hou X, Purfeerst ER, Heinzen EP, Correia C, Huntoon CJ, O’Brien D, Wahner Hendrickson AE, Dowdy SC, Li H, Oberg AL, Hitosugi T, Kaufmann SH, Weroha SJ, Karnitz LM. BRCA1 deficiency upregulates NNMT, which reprograms metabolism and sensitizes ovarian cancer cells to mitochondrial metabolic targeting agents. Cancer Res. 2019;79:5920–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kong Y, Akatsuka S, Motooka Y, Zheng H, Cheng Z, Shiraki Y, Mashimo T, Imaoka T, Toyokuni S. BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance. Redox Biol. 2022;54: 102356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Shi Y-Q, Zhu X-T, Zhang S-N, Ma Y-F, Han Y-H, Jiang Y, Zhang Y-H. Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants. Front Endocrinol. 2023;14:1172481.

    Article  Google Scholar 

  37. Wang H, Meng Q, Qian J, Li M, Gu C, Yang Y. Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer. Pharmacol Ther. 2022;234: 108123.

    Article  CAS  PubMed  Google Scholar 

  38. Wang X, Song Z, Hu B, Chen Z, Chen F, Cao C. MicroRNA-642a-5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1. Oncol Rep. 2021;45:933–44.

    Article  PubMed  Google Scholar 

  39. Beveridge DJ, Richardson KL, Epis MR, Brown RAM, Stuart LM, Woo AJ, Leedman PJ. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Sci Rep. 2021;11:18003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Han Q, Guo X, Jia K, Jing J, Dang W, Li Y, Qin X, Li P, Ren Y, Liu W, Kebreab E, Lyu L. Effects of FOXO1 on the proliferation and cell cycle-, apoptosis- and steroidogenesis-related genes expression in sheep granulosa cells. Anim Reprod Sci. 2020;221: 106604.

    Article  CAS  PubMed  Google Scholar 

  41. Wen J, Lv R, Ma H, Shen H, He C, Wang J, Jiao F, Liu H, Yang P, Tan L, Lan F, Shi YG, He C, Shi Y, Diao J. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69:1028-1038.e6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Huang J, Sun W, Wang Z, Lv C, Zhang T, Zhang D, Dong W, Shao L, He L, Ji X, Zhang P, Zhang H. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J Exp Clin Cancer Res CR. 2022;41:42.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research was supported by grants from the National Natural Science Foundation of China (Grant No.82172838), 333 Project Excellent Young Talents Project of Jiangsu Province, Key Medical Research Projects of Jiangsu Provincial Health Commission, and Social Development Project of Zhenjiang, Jiangsu Province (Grant No. SH2023057).

Author information

Author notes

  1. Xiaolan Zhu, Wenxin Li and Minjun Lu have contributed equally to this work.

Authors and Affiliations

  1. Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University, No. 20 Zhengdong Road, Zhenjiang, 212001, Jiangsu, China

    Xiaolan Zhu, Wenxin Li, Minjun Lu, Junyu Shang, Jiamin Zhou, Li Lin, Yueqin Liu, Jie Xing, Mengxue Zhang, Shijie Zhao, Jingjing Lu & Xuyan Shi

  2. Department of Central Laboratory, The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China

    Xiaolan Zhu, Wenxin Li, Minjun Lu, Junyu Shang, Jiamin Zhou, Li Lin, Yueqin Liu, Jie Xing, Mengxue Zhang, Shijie Zhao, Jingjing Lu & Xuyan Shi

  3. Reproductive Sciences Institute, Jiangsu University, Zhenjiang, China

    Xiaolan Zhu

Authors
  1. Xiaolan Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenxin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minjun Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junyu Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiamin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yueqin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jie Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mengxue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shijie Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jingjing Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xuyan Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XZ designed this study. XZ and LL obtained the funding.WL, ML, LL, YL, JX, MZ, SZ, JL and XS performed the clinical studies. WL, ML, JS, and JZ performed the experiments. WL wrote the manuscript. XZ revised the manuscript. All authors read, revised, and approved the final manuscript.

Corresponding author

Correspondence to Xiaolan Zhu.

Ethics declarations

Ethics approval and consent to participate

The collection of patients' GCs and serum samples was approved by the Ethics Committee of The Fourth Affiliated Hospital of Jiangsu University (Zhenjiang Maternal and Child Health Hospital), which was in accordance with the ethical requirements, and all subjects participated voluntarily and signed a written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, X., Li, W., Lu, M. et al. M6A demethylase FTO-stabilized exosomal circBRCA1 alleviates oxidative stress-induced granulosa cell damage via the miR-642a-5p/FOXO1 axis. J Nanobiotechnol 22, 367 (2024). https://doi.org/10.1186/s12951-024-02583-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12951-024-02583-5

Keywords

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us